2021
DOI: 10.1002/brb3.2374
|View full text |Cite
|
Sign up to set email alerts
|

Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment

Abstract: Purpose:We investigated the blink profiles and blink index using ocular surface interferometer in the patients with blepharospasm (BSP) and identified points to consider predictive factor after BSP treatment. Methods:In total, 117 eyelids of 59 elderly patients and 20 eyelids of 10 age-matched control group were studied. All BSP patients applied botulinum toxin-A (BoNT-A) injection for treatment of BSP. An ocular surface interferometer (LipiView; TearScience, Morrisville, NC, USA) was used to measure blink pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…Comparing the two responder groups to BoNT-A injection, the previous study reported that the poor responders exhibited a different blink profile such as increased lid closure time and decreased closing speed, including apraxia of eyelid opening ( 31 ). Therefore, a more detailed classification of BSP is required, along with a revised approach to treatment selection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Comparing the two responder groups to BoNT-A injection, the previous study reported that the poor responders exhibited a different blink profile such as increased lid closure time and decreased closing speed, including apraxia of eyelid opening ( 31 ). Therefore, a more detailed classification of BSP is required, along with a revised approach to treatment selection.…”
Section: Discussionmentioning
confidence: 99%
“…Good responders were patients who improved to 0 or 1 on the rating scale and maintained the same injection dose at the next injection as that applied at the initial injection. Poor responders were patients who exhibited >2 points on the rating scale at the initial injection, along with an increase of 50% in the BoNT-A dose at the next injection ( 31 ).…”
Section: Methodsmentioning
confidence: 99%
“…They also observed reduced amplitude and peak velocity of blinks on the treated side. Jang et al 18 retrospectively analyzed 20-second videos using LipiView Interferometer (TearScience, Morrisville, NC) in BSP patients. In contrast to our results, they did not find significant differences between BSP and control patients or differences in closing velocity in BSP patients after BoNT-A injections.…”
Section: Discussionmentioning
confidence: 99%
“…The eye closure rate which was measured in this study is different from the blink rate because we included any type of eye closure in the measurements, including blinks and spasms. Increased blink rate alone has been used as a simple measure to assess response to treatment in blepharospasm [ 18 ] but it has low specificity and sensitivity for the diagnosis of BSP [ 9 ] and its pathophysiology may be different than orbicularis oculi muscle spasms [ 19 ]. Another limitation is the relatively low number of participants which may not be adequate for such a high number of comparisons.…”
Section: Discussionmentioning
confidence: 99%